Medical Innovation Exchange

Alnylam culls 3 programs, including nephropathy med that was slated for ph. 3

https://www.fiercebiotech.com/biotech/alnylam-culls-three-programs-including-nephropathy-med-was-slated-ph-3

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!